Skip to main content
OpenTrials
Completed

NCT Number: NCT04825561

A Study to Evaluate the Efficacy and Safety of AD-208

The purpose of this study is to evaluate the efficacy and safety of AD-208.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Androgenetic Alopecia Alopecia Hair Diseases Hypotrichosis Pathological Conditions, Anatomical Pathological Conditions, Signs and Symptoms Skin Diseases Skin and Connective Tissue Diseases

Age range

18 year–50 year

Sex eligibility

Male

Study type

Interventional

Phase

Phase 3

Primary location

The Catholic University of Korea, Eunpyeong St. Mary's Hospital

Seoul, South Korea

About this study

The purpose of this study is to evaluate the efficacy and safety of AD-208 in male patients with androgenetic alopecia.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male patients aged 18-50 years, inclusive
  • Patients who meet the appropriate criteria according to the classification of hair loss
  • Signed informed consent

Exclusion criteria

  • Patients with hair loss disorders other than androgenetic alopecia
  • Other exclusions applied

Treatment and study plan

AD-208

Drug

PO, Once daily(QD), 24weeks

AD-2081

Drug

PO, Once daily(QD), 24weeks

placebo of AD-208

Drug

PO, Once daily(QD), 24weeks

placebo of AD-2081

Drug

PO, Once daily(QD), 24weeks

Primary outcomes

  1. The amount of Change in the total number of hairs

    Time frame: Baseline, Week 24

    The amount of change in the total number of hairs in the unit area

Sponsors and collaborators

Lead sponsor

Addpharma Inc.

Industry

Registry information

Official study title

A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of AD-208 in Male Patients With Androgenetic Alopecia

Important dates

Study start
2021
Primary completion
2023
Study completion
2023
First posted
Apr 1, 2021
Registry last updated
Jul 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.